Welcome : Guest

HIGH CONTENT SCREENING (HCS) - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for High Content Screening (HCS) in US$ Million. The Global market is further analyzed by the following Segments: Consumables, Instruments, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 71 companies including many key and niche players such as -

BD Biosciences
BioTek Instruments Inc.
EMD Millipore
Evotec AG
Essen BioScience
GE Healthcare Life Sciences

Click here to request a full list of companies covered in the report...

Code: MCP-6754
Price: $4500
Companies: 71
Pages: 194
Date: March 2018
Market Data Tables: 36
  Status: * New Report



TABLE OF CONTENTS


  HIGH CONTENT SCREENING (HCS) (Complete Report) Pages : 194   | $4500

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   HCS – An Evolving Screening Technology.....II-11$100
   HCS Market Ripe with Growth Opportunity.....II-2
Key Growth Drivers.....II-2
1$100
   Key Challenges.....II-3
Market Outlook.....II-3
Developing Regions Drive Future Growth.....II-3
1$100
   Table 1: Global High Content Screening (HCS) Market - Geographic Regions Ranked by CAGR for 2016-2024 (includes corresponding Graph/Chart).....II-4
HCS Software – A High Growth Market.....II-4
Equipment Sales Continue to Expand.....II-4
1$350
   Competitive Overview.....II-5
Table 2: Leading Players in the Global HCS Market (2017E): Percentage Share Breakdown of Sales by Company (includes corresponding Graph/Chart).....II-5
1$350
   HCA – Playing an Important Role in Primary Screening.....II-6
Table 3: Global Screening Market (2017): Percentage Share Breakdown by Segment - Primary Screening, Secondary Screening and Leads-to-Candidate (ADME/Tox Screening) (includes corresponding Graph/Chart).....II-6
1$350
   Technology Advancements Drive Market Growth.....II-7
HCS Instruments for Analysis of 3D Cell Models.....II-7
1$100
   Emergence of Academic Sector as the Major User of HCS.....II-8
Table 4: HCS Budget of a Typical Research Company (includes corresponding Graph/Chart).....II-8
1$350
   Table 5: Global High-Throughput Screening Market (2017): Percentage Breakdown of Sales by End-use Segment (includes corresponding Graph/Chart).....II-9
Stem Cell Biology – An Emerging Area of Interest.....II-9
1$350
   HCS Specific Data Analysis Systems – The Need of the Hour.....II-101$100
   HCS vs. HTS.....II-11
Rise in Adoption of HCS Technology in HTS Laboratories.....II-11
1$100
   Market Challenges.....II-12
High Instrumentation Costs Hamper Rapid Growth.....II-12
1$100
   Defining High Content Screening.....II-13
The Process of High Content Screening.....II-13
1$100
   The Process of High Content Screening.....II-141$100
   Technology Evolution Over the Years.....II-15
HCS Tools.....II-15
List of HCS Tools.....II-15
1$100
   HCS Imaging – Categories.....II-16
Instrumentation.....II-16
Consumables.....II-16
Software.....II-16
Services.....II-16
1$100
   Genedata Launches Early Access Program to Deep Learning for High Content Screening
  (HCS) Image Analysis.....II-17
Yokogawa Electric Releases the CellVoyager® CV8000.....II-17
Molecular Devices launches ImageXpress® Micro 4 High-Content Imaging System.....II-17
1$100
   Sartorius Acquires Umetrics and Essen BioScience.....II-18
Evotec Signs Deal with Genedata Screener for Drug Discovery Data Management.....II-18
Sartorius Acquires IntelliCyt.....II-18
AstraZeneca Signs Agreement with IntelliCyt for the Development of High Throughput
  Biology Applications.....II-18
ONO PHARMACEUTICAL Extends Genedata Screener® License.....II-18
1$100
   BD Biosciences (USA).....II-19
BioTek Instruments Inc. (USA).....II-19
EMD Millipore (USA).....II-19
1$100
   Evotec AG (Germany).....II-20
Essen BioScience (USA).....II-20
1$100
   GE Healthcare Life Sciences (Sweden).....II-21
Genedata AG (Switzerland).....II-21
IntelliCyt Corporation (USA).....II-21
Molecular Devices, Inc. (USA).....II-21
1$100
   PerkinElmer, Inc. (USA).....II-221$100
   Thermo Fisher Scientific, Inc. (USA).....II-23
Thorlabs, Inc. (USA).....II-23
1$100
   TTP LabTech Ltd. (UK).....II-24
Yokogawa Electric Corporation (Japan).....II-24
1$100
   Table 6: World Recent Past, Current & Future Analysis for High Content Screening by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-251$350
   Table 7: World Historic Review for High Content Screening by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-261$350
   Table 8: World 14-Year Perspective for High Content Screening by Geographic Region/Country - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-271$350
   Table 9: World Recent Past, Current & Future Analysis for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-281$350
   Table 10: World Historic Review for High Content Screening by Segment - Consumables, Instruments, and Others Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-291$350
   Table 11: World 14-Year Perspective for High Content Screening by Segment - Percentage Breakdown of Revenues for Consumables, Instruments, and Others Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-301$350
   A. Market Analysis.....III-1
Market Overview.....III-1
Product Launch.....III-1
1$75
   Strategic Corporate Developments.....III-2
Key Players.....III-2
5$375
   B. Market Analytics.....III-7
Table 12: US Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-7
1$200
   Table 13: US Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-81$200
   Market Analysis.....III-9
Table 14: Canadian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-9
1$200
   Table 15: Canadian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-101$200
   A. Market Analysis.....III-11
Product Launch.....III-11
Key Player.....III-11
1$75
   B. Market Analytics.....III-12
Table 16: Japanese Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-12
1$200
   Table 17: Japanese Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-131$200
   Market Analysis.....III-14
Table 18: European Recent Past, Current & Future Analysis for High Content Screening by Geographic Region/Country - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-14
1$200
   Table 19: European Historic Review for High Content Screening by Geographic Region/Country - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-151$200
   Table 20: European 14-Year Perspective for High Content Screening by Geographic Region/ Country - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-161$200
   Market Analysis.....III-17
Table 21: French Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-17
1$200
   Table 22: French Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-181$200
   A. Market Analysis.....III-19
Strategic Corporate Development.....III-19
Key Player.....III-19
1$75
   B. Market Analytics.....III-20
Table 23: German Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-20
1$200
   Table 24: German Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-211$200
   Market Analysis.....III-22
Table 25: Italian Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-22
1$200
   Table 26: Italian Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Strategic Corporate Development.....III-24
Key Player.....III-24
1$75
   B. Market Analytics.....III-25
Table 27: UK Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-25
1$200
   Table 28: UK Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-261$200
   Market Analysis.....III-27
Table 29: Spanish Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-27
1$200
   Table 30: Spanish Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Product Launch.....III-29
Strategic Corporate Development.....III-29
Key Players.....III-29
2$150
   B. Market Analytics.....III-31
Table 31: Rest of Europe Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-31
1$200
   Table 32: Rest of Europe Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-321$200
   A. Market Analysis.....III-33
Select Regional Analysis.....III-33
China.....III-33
China Emerges As The Major Outsourcer for Drug Discovery.....III-33
1$75
   India.....III-341$75
   B. Market Analytics.....III-35
Table 33: Asia-Pacific Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-35
1$200
   Table 34: Asia-Pacific Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-361$200
   Market Analysis.....III-37
Table 35: Rest of World Recent Past, Current & Future Analysis for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-37
1$200
   Table 36: Rest of World Historic Review for High Content Screening Market Analyzed with Annual Revenues in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-381$200
  
Total Companies Profiled: 73 (including Divisions/Subsidiaries - 80)

Region/Country Players

The United States 36 Japan 3 Europe 36 France 6 Germany 9 The United Kingdom 11 Italy 1 Spain 1 Rest of Europe 8 Asia-Pacific (Excluding Japan) 3 Middle East 2
Click here to request a full table of contents and more details on this project.